$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Instructions for use of Atrasentan in patients with IgA nephropathy
2026-02-01 22:25:32
Check Details
What is the Chinese name of Guanfacine?
2026-02-01 22:25:32
Check Details
Do I need to take Bitovil/Bikonprofen tablets on time every day? Medication timing and compliance recommendations
2026-02-01 22:25:32
Check Details
An in-depth interpretation of the instructions for deuterated colexitinib
2026-02-01 22:25:32
Check Details
The price of Apremilast/Apremilast tablets revealed: How much does a box cost?
2026-02-01 22:25:32
Check Details
Can't I stop taking Valganciclovir once I take it? Discontinuation precautions and risks
2026-02-01 22:25:32
Check Details
Detailed explanation of the instructions for the antihypertensive drug Aprecitentan: from indications, treatment effects to medication precautions
2026-02-01 22:25:32
Check Details
Why is Guanfacine not recommended?
2026-02-01 22:25:32
Check Details
SURMOUNT-1 trial finds tilsiparatide/tilpotide supports long-term weight control
2026-02-01 22:25:32
Check Details
Is Pitobrutinib/Pitobrutinib launched in China? The latest news is here!
2026-02-01 22:25:32
Check Details
What is the effect of talazoparib/talazopanib combined with enzalutamide? Advantages and efficacy of combination therapy
2026-02-01 22:25:32
Check Details
What kind of lung cancer does Crizotinib/Xalkori treat? Detailed explanation of indications and clinical data
2026-02-01 22:25:32
Check Details
1
2
...
1481
1482
1483
1484
1485
1486
1487
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
2
Cemiplimab Storage and Handling Guide
3
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
4
FDA Approves First mRNA Flu Vaccine mFLUSIVA
5
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
6
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
7
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
8
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
9
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
10
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor
11
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
12
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer